OGT Licenses Patents to Biotype Diagnostics for Microarray Technology Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has licensed its patents for detecting DNA sequence variations to Biotype Diagnostics, which will use it to develop a microarray platform.

The rights are valid for the lifetime of the patents and give Biotype certain rights with respect to SNP genotyping, OGT said in a statement. Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.